Ocimum Biosolutions in Deloitte Fast 500 Asia Pacific List
Hyderabad, India – December 10, 2007 – Ocimum Biosolutions, a leading integrated life sciences solutions company, has been listed in the Deloitte Technology Fast 500 Asia Pacific ranking, for the third consecutive year. Ocimum had featured in Deloitte Technology Fast 500 Asia Pacific ranking in the years 2005 and 2006 as well. Ocimum is also listed in Deloitte Technology Fast 50 India ranking, for all the three years. The Deloitte Technology Fast 500 Asia Pacific list is a ranking of the 500 fastest growing technology companies in Asia Pacific, based on the percentage revenue growth over three financial years.
About the Deloitte Technology Fast 500 Asia Pacific:
The Deloitte Technology Fast 500 Asia Pacific program is the region’s most objective industry-ranking standard to focus on the technology field. The ranking acknowledges and profiles the top 500 technology companies — public and private — and the winners are ranked according to their revenue performance over the last three years. The top five companies this year achieved average three-year revenue growth rates ranging from 9,409 to 27,542 percent. Details of the winning companies are available at:
http://www.deloitte.com/dtt/cda/doc/content/Deloitte%20Technology%20Fast500%20Asia%20Pacific%20Winners%20Report.pdf
About Deloitte:
Deloitte refers to one or more of Deloitte Touche Tohmatsu, a Swiss Verein, its member firms, and their respective subsidiaries and affiliates. Deloitte Touche Tohmatsu is an organization of member firms around the world devoted to excellence in providing professional services and advice, focused on client service through a global strategy executed locally in over 140 countries. With access to the deep intellectual capital of approximately 150,000 people worldwide, Deloitte delivers services in four professional areas – audit, tax, consulting, and financial advisory services – and serves more than 80 percent of the world’s largest companies, as well as large national enterprises, public institutions, locally important clients, and successful, fast-growing global companies. Services are not provided by the Deloitte Touche Tohmatsu Verein, and, for regulatory and other reasons, certain member firms do not provide services in all four professional areas. As a Swiss Verein (association), neither Deloitte Touche Tohmatsu nor any of its member firms have any liability for each other’s acts or omissions. Each of the member firms is a separate and independent legal entity operating under the names “Deloitte,” “Deloitte & Touche,” “Deloitte Touche Tohmatsu,” or other related names.
About Ocimum Biosolutions:
Ocimum Biosolutions is a life sciences R&D enabling company with three focus areas, BioIT, BioMolecules, and BioResearch. Ocimum delivers end to end genomic products and services out of three strategic locations worldwide, Indianapolis (United States), IJsselstien (The Netherlands), Hyderabad (India).
The BioIT Division provides key, ready to use, reliable, cost-effective software solutions for the biotech/pharma industry. This division includes three 21 CFR Part 11 & GLP compliant, Lab Information Management Systems (LIMS) products – Biotracker™, Pharmatracker™ and Toxchek™ and a suite of bioinformatics products, Genchek™ (sequence analysis), OptGene™ (gene design), Genowiz™ (microarray data analysis) and iRNAchek™ (iRNA template design). The division also offers data mining, literature mining, algorithm development, gene identification, multiple-platform software development, database creation and manipulation, and tools for image analysis.
The BioMolecules Division produces microarrays and oligonucleotides. The Microarray Division has been recently acquired from MWG Biotech (Germany) and produces catalog OciChip™ arrays, Custom OciChip™ arrays and offers microarray hybridization services. The Oligonucleotides Division, which has been acquired from Isogen Life Science (The Netherlands), makes standard and modified DNA, RNA oligonucleotides.
The BioResearch Division provides molecular biology services like GMO testing, nucleic acid purification, DNA extractions and gene synthesis. The U.S arm of Ocimum Biosolutions is located at Indianapolis. For more information please visit www.ocimumbio.com.
